Cargando…

Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients

RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Jedrzej, Shmeleva, Evgeniya V., Boag, Stephen E., Fiser, Karel, Bagnall, Alan, Murali, Santosh, Dimmick, Ian, Pircher, Hanspeter, Martin-Ruiz, Carmen, Egred, Mohaned, Keavney, Bernard, von Zglinicki, Thomas, Das, Rajiv, Todryk, Stephen, Spyridopoulos, Ioakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280279/
https://www.ncbi.nlm.nih.gov/pubmed/25385851
http://dx.doi.org/10.1161/CIRCRESAHA.116.304393
_version_ 1782350832030711808
author Hoffmann, Jedrzej
Shmeleva, Evgeniya V.
Boag, Stephen E.
Fiser, Karel
Bagnall, Alan
Murali, Santosh
Dimmick, Ian
Pircher, Hanspeter
Martin-Ruiz, Carmen
Egred, Mohaned
Keavney, Bernard
von Zglinicki, Thomas
Das, Rajiv
Todryk, Stephen
Spyridopoulos, Ioakim
author_facet Hoffmann, Jedrzej
Shmeleva, Evgeniya V.
Boag, Stephen E.
Fiser, Karel
Bagnall, Alan
Murali, Santosh
Dimmick, Ian
Pircher, Hanspeter
Martin-Ruiz, Carmen
Egred, Mohaned
Keavney, Bernard
von Zglinicki, Thomas
Das, Rajiv
Todryk, Stephen
Spyridopoulos, Ioakim
author_sort Hoffmann, Jedrzej
collection PubMed
description RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosenescence in cytomegalovirus-seropositive patients. METHODS AND RESULTS: Thirty-four patients with acute myocardial infarction undergoing primary percutaneous coronary intervention were longitudinally studied within 3 months after reperfusion (Cohort A). In addition, 54 patients with acute myocardial infarction and chronic myocardial infarction were analyzed in a cross-sectional study (Cohort B). Cytomegalovirus-seropositive patients demonstrated a greater fall in the concentration of terminally differentiated CD8 effector memory T cells (T(EMRA)) in peripheral blood during the first 30 minutes of reperfusion compared with cytomegalovirus-seronegative patients (−192 versus −63 cells/μL; P=0.008), correlating with the expression of programmed cell death-1 before primary percutaneous coronary intervention (r=0.8; P=0.0002). A significant proportion of T(EMRA) cells remained depleted for ≥3 months in cytomegalovirus-seropositive patients. Using high-throughput 13-parameter flow cytometry and human leukocyte antigen class I cytomegalovirus-specific dextramers, we confirmed an acute and persistent depletion of terminally differentiated T(EMRA) and cytomegalovirus-specific CD8(+) cells in cytomegalovirus-seropositive patients. Long-term reconstitution of the T(EMRA) pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was associated with signs of terminal differentiation including an increase in killer cell lectin-like receptor subfamily G member 1 and shorter telomere length in CD8(+) T cells (2225 versus 3397 bp; P<0.001). CONCLUSIONS: Myocardial ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous coronary intervention leads to acute loss of antigen-specific, terminally differentiated CD8 T cells, possibly through programmed cell death-1–dependent programmed cell death. Our results suggest that acute myocardial infarction and reperfusion accelerate immunosenescence in cytomegalovirus-seropositive patients.
format Online
Article
Text
id pubmed-4280279
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-42802792015-01-06 Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients Hoffmann, Jedrzej Shmeleva, Evgeniya V. Boag, Stephen E. Fiser, Karel Bagnall, Alan Murali, Santosh Dimmick, Ian Pircher, Hanspeter Martin-Ruiz, Carmen Egred, Mohaned Keavney, Bernard von Zglinicki, Thomas Das, Rajiv Todryk, Stephen Spyridopoulos, Ioakim Circ Res Clinical Track RATIONALE: There is mounting evidence of a higher incidence of coronary heart disease in cytomegalovirus-seropositive individuals. OBJECTIVE: The aim of this study was to investigate whether acute myocardial infarction triggers an inflammatory T-cell response that might lead to accelerated immunosenescence in cytomegalovirus-seropositive patients. METHODS AND RESULTS: Thirty-four patients with acute myocardial infarction undergoing primary percutaneous coronary intervention were longitudinally studied within 3 months after reperfusion (Cohort A). In addition, 54 patients with acute myocardial infarction and chronic myocardial infarction were analyzed in a cross-sectional study (Cohort B). Cytomegalovirus-seropositive patients demonstrated a greater fall in the concentration of terminally differentiated CD8 effector memory T cells (T(EMRA)) in peripheral blood during the first 30 minutes of reperfusion compared with cytomegalovirus-seronegative patients (−192 versus −63 cells/μL; P=0.008), correlating with the expression of programmed cell death-1 before primary percutaneous coronary intervention (r=0.8; P=0.0002). A significant proportion of T(EMRA) cells remained depleted for ≥3 months in cytomegalovirus-seropositive patients. Using high-throughput 13-parameter flow cytometry and human leukocyte antigen class I cytomegalovirus-specific dextramers, we confirmed an acute and persistent depletion of terminally differentiated T(EMRA) and cytomegalovirus-specific CD8(+) cells in cytomegalovirus-seropositive patients. Long-term reconstitution of the T(EMRA) pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was associated with signs of terminal differentiation including an increase in killer cell lectin-like receptor subfamily G member 1 and shorter telomere length in CD8(+) T cells (2225 versus 3397 bp; P<0.001). CONCLUSIONS: Myocardial ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous coronary intervention leads to acute loss of antigen-specific, terminally differentiated CD8 T cells, possibly through programmed cell death-1–dependent programmed cell death. Our results suggest that acute myocardial infarction and reperfusion accelerate immunosenescence in cytomegalovirus-seropositive patients. Lippincott Williams & Wilkins 2015-01-02 2014-12-31 /pmc/articles/PMC4280279/ /pubmed/25385851 http://dx.doi.org/10.1161/CIRCRESAHA.116.304393 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wolters Kluwer. © 2014 The Authors. Circulation Research is published on behalf of the American Heart Association, Inc., by Wolters Kluwer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Track
Hoffmann, Jedrzej
Shmeleva, Evgeniya V.
Boag, Stephen E.
Fiser, Karel
Bagnall, Alan
Murali, Santosh
Dimmick, Ian
Pircher, Hanspeter
Martin-Ruiz, Carmen
Egred, Mohaned
Keavney, Bernard
von Zglinicki, Thomas
Das, Rajiv
Todryk, Stephen
Spyridopoulos, Ioakim
Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title_full Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title_fullStr Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title_full_unstemmed Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title_short Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
title_sort myocardial ischemia and reperfusion leads to transient cd8 immune deficiency and accelerated immunosenescence in cmv-seropositive patients
topic Clinical Track
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280279/
https://www.ncbi.nlm.nih.gov/pubmed/25385851
http://dx.doi.org/10.1161/CIRCRESAHA.116.304393
work_keys_str_mv AT hoffmannjedrzej myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT shmelevaevgeniyav myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT boagstephene myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT fiserkarel myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT bagnallalan myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT muralisantosh myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT dimmickian myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT pircherhanspeter myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT martinruizcarmen myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT egredmohaned myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT keavneybernard myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT vonzglinickithomas myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT dasrajiv myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT todrykstephen myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients
AT spyridopoulosioakim myocardialischemiaandreperfusionleadstotransientcd8immunedeficiencyandacceleratedimmunosenescenceincmvseropositivepatients